Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1977-07-05
1978-08-15
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 424251, 544283, G01N 3316, C07D23900
Patent
active
041072855
ABSTRACT:
A sensitive radioimmunoassay for methaqualone and its major metabolites is described. Included within this disclosure is the preparation of novel methaqualone haptens, the preparation of antigens from such haptens by coupling to an immunogenic carrier material, the use of such antigens to elicit antibodies selective to methaqualone and its major metabolites and an improved radiolabelled derivative of a methaqualone analog used in the practice of said radioimmunoassay.
REFERENCES:
patent: 3690834 (1972-09-01), Goldstein
patent: 4053459 (1977-10-01), Christenson
Berman et al., Clinical Chemistry, vol. 21, No. 13, 1975.
Gould George M.
Hoffmann-La Roche Inc.
Nucker Christine M.
Padgett Benjamin R.
Welt Samuel L.
LandOfFree
Radioimmunoassay for methaqualone does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radioimmunoassay for methaqualone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radioimmunoassay for methaqualone will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1435245